Tubridy, Niall

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Illness perception and health-related quality of life in multiple sclerosis.

Spain, L. A., Tubridy, N., Kilpatrick, T. J., Adams, S. J., & Holmes, A. C. N. (2007) · Acta Neurologica Scandinavica

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 97

Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis

Rubio, J. P., Tubridy, N., Bahlo, M., Stankovich, J., Burfoot, R., Butzkueven, H., Chapman, C., Johnson, L., Marriott, M., Mraz, G., et al. (2004) · Human Genetics

Multiple Sclerosis Research StudiesGenetic Associations and Epidemiology

Cited by 43

Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice

Kelly, S., Chaila, E., Kinsella, K., Duggan, M., McGuigan, C., Tubridy, N., & Hutchinson, M. (2011) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 30

Neuropsychology intervention for managing invisible symptoms of MS (NIMIS-MS) group: A pilot effectiveness and acceptability study

O'Keeffe, F., Cogley, C., McManus, C., Davenport, L., O'Connor, S., Tubridy, N., Gaughan, M., McGuigan, C., & Bramham, J. (2024) · Multiple Sclerosis and Related Disorders

Multiple Sclerosis Research StudiesMindfulness and Compassion Interventions

Cited by 4